Role of Antioxidants in Unexplained Oligohydramnios,A Randomized Trial

• Status: Completed
• Trial end date: 2015-08-01
• Target enrollment: 0
• Participant gender: Female

Summary

To predict the effect of antioxidants in cases of oligohydramnios

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Woman's Health University Hospital, Egypt
• Treatments: Antioxidants

Criteria

Inclusion Criteria:

• Patients with gestational age between 30-34 weeks with:

• Oligohydramnios of unknown cause.

Exclusion Criteria:

• 1- Premature rupture of membranes. 2- Oligohydramnios in postdates pregnancy (>41 weeks). 3- Fetal anomalies. 4- IUGR. 5- Patients using non steroidal anti-inflammatory drugs. 6 - Oligohydramnios assosiatd with Pregnancy induced hypertension (PIH).